Home - Life Sciences Times

Life Sciences

Mass Biotech Council Vice President Ben Bradford to Speak at Boston Life Sciences and Medical Facilities Conference

Life Sciences Times - April 3, 2025

Venture Capital

AIRNA Secures $155 Million in Oversubscribed Series B Funding to Advance RNA Editing Therapies

Life Sciences

MassBio Welcomes Six Members to 2025 Board of Directors

Life Sciences

MassBio Honors Eli Lilly and RedPoint Oncology Among Others at its Annual Conference

LATEST NEWS

Medtech

eClinical Solutions Report Highlights Shift Toward Risk-Based Strategies and AI Challenges in Clinical Trials

Life Sciences Times - April 3, 2025 0

BOSTON-- As the life sciences industry looks to transform clinical research through innovation, a new report from eClinical Solutions reveals a growing emphasis on...

FDA Rejects Aldeyra Therapeutics’ Resubmission for Dry Eye Drug Reproxalap

April 3, 2025

KARL STORZ Launches Slimline C-MAC S Single-Use Video Laryngoscope

April 3, 2025

New Book Provides AI-Powered Playbook for Modernizing Healthcare Workforce Management

April 3, 2025

United Digestive Taps eClinicalWorks’ AI-Powered healow Genie to Enhance Patient Access and Streamline Practice Operations

April 3, 2025

PHARMA

Pharma

FDA Rejects Aldeyra Therapeutics’ Resubmission for Dry Eye Drug Reproxalap

Life Sciences Times - April 3, 2025 0

LEXINGTON, Mass.-- ldeyra Therapeutics (Nasdaq: ALDX) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the...

Palleon Pharmaceuticals and Henlius Receive NMPA Approval for Phase 2 Trial of E-602 in Autoimmune Diseases

April 2, 2025

Cycle Vita Expands Multiple Sclerosis Patient Support to Include BAFIERTAM

March 31, 2025

Arbutus Biopharma Implements Significant Workforce Reduction as Part of Strategic Restructuring

March 31, 2025

European Commission Approves Merck’s CAPVAXIVE® Vaccine for Prevention of Pneumococcal Disease in Adults

March 31, 2025

Medtech

eClinical Solutions Report Highlights Shift Toward Risk-Based Strategies and AI Challenges in Clinical Trials

Medtech

KARL STORZ Launches Slimline C-MAC S Single-Use Video Laryngoscope

Medtech

United Digestive Taps eClinicalWorks’ AI-Powered healow Genie to Enhance Patient Access and Streamline Practice Operations

Healthcare

Wolters Kluwer and Laerdal Medical Introduce Conversational AI to VR Nursing Simulation

Real Estate

BioMed Realty Acquires 75 Broadway, a Life Science Development to be Biogen’s New Global Headquarters

Life Sciences Times - March 25, 2025 0

Cambridge, MA- BioMed Realty, a Blackstone portfolio company and the largest private operator of life science real estate, announced the acquisition of a majority...

Suffolk Hires Experienced Construction Leader Evan McKee as COO in Dallas to Drive Regional Growth and Diversification

March 25, 2025

Biogen Will Have a New Global Headquarters and Innovation Hub in Kendall Square in Cambridge, MA

March 25, 2025

Life Sciences

Mass Biotech Council Vice President Ben Bradford to Speak at Boston Life Sciences and Medical Facilities Conference

Life Sciences Times - April 3, 2025 0

BOSTON— The Boston Life Sciences, Biotech, Pharma & Medical Facilities Conference 2025 is set to feature a distinguished lineup of industry leaders, including Ben...

Initial Speakers for Announced for Boston Life Sciences, Biotech, Pharma & Medical Facilities Conference 2025

Life Sciences Times - April 1, 2025 0

BOSTON — The Boston Life Sciences, Biotech, Pharma, and Medical Facilities Conference is set to be one of the most pivotal industry gatherings of...

Science Exchange Acquires HappiLabs to Enhance Scientific Procurement Capabilities

Life Sciences Times - March 31, 2025 0

PALO ALTO, Calif.— Science Exchange, a leader in life sciences procurement and supplier management software, has announced the acquisition of HappiLabs, a Chicago-based company...

Charles River and Valo Health Discover Potential Lupus Treatment Using AI-Powered Drug Platform

Life Sciences Times - March 31, 2025 0

CAMBRIDGE, Mass. — Charles River Laboratories International, Inc. and Valo Health, Inc. announced the identification of a promising drug candidate for the treatment of...

Vertex Pharmaceuticals Announces Updates on Type 1 Diabetes Portfolio

Life Sciences Times - March 31, 2025 0

BOSTON – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) provided key updates on its Type 1 Diabetes (T1D) portfolio, which includes progress on clinical trials for...

Today's Headlines

FDA Rejects Aldeyra Therapeutics’ Resubmission for Dry Eye Drug Reproxalap

Life Sciences Times - April 3, 20250

Pharma

LEXINGTON, Mass.-- ldeyra Therapeutics (Nasdaq: ALDX) announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the...